Marcadia Biotech is a company that is focused on developing therapeutic products that will greatly improve the daily life of people with diabetes and obesity. Utilizing their proprietary peptide chemistry, the company has a portfolio of compounds in its discovery and development pipeline. The first product in development is a glucagon injector pen for emergency use to counteract severe hypoglycemia (low blood sugar).

Marcadia Biotech’s other discovery and product development efforts are being targeted to treat and reduce complications of diabetes and obesity.